Experts concerned about C. diff infections

09/3/2009 | Healthcare Finance News

A survey found infectious disease specialists are concerned about new strains and the relapse and recurrence of hospital-acquired Clostridium difficile infections, which are very difficult to treat. The experts called for new and better drugs, including second- and later-line therapies.

View Full Article in:

Healthcare Finance News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance Director
Abbott Laboratories
Santa Clara, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA